Cardiology

US emergency room visits for irregular heartbeat soar

Emergency room visits for atrial fibrillation have increased significantly in the United States—causing a major healthcare burden, according to research presented at the American Heart Association's Scientific Sessions ...

Medications

Bristol-Myers, Pfizer's Eliquis approved in Japan

Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...

Cardiology

Fish oil supplements have little effect on irregular heartbeat

High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD ...

Oncology & Cancer

Arrhythmia drug may increase cancer risk

One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study ...

Medications

FDA approves drug to reverse blood thinner Pradaxa

Federal health regulators have approved a drug to reverse the blood-thinning effects of the popular pill Pradaxa, which has been subject to thousands of reports of severe bleeding.

page 9 from 21